InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Ward Scott R., Chief Executive Officer. Officer active across 2 companies, notably Cardiovascular Systems Inc. Cumulatively, 20 filings have been published. Split: 6 buys · 0 sell. Total volume traded: €179k. History available since 10 May 2021. The latest transaction was filed on 7 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations20 total
16,245 shares0Common StockSEC:0001493152-25-001735:0
578,310 shares@ US$20.0088.3% of flowCommon StockSEC:0001062993-23-009593:0
1,493 shares@ US$19.700.2% of flowCommon StockSEC:0001062993-23-003440:0
77,028 shares0Common StockSEC:0001437749-22-021197:0
16,006 shares@ US$16.642.2% of flowCommon StockSEC:0001437749-22-020769:0
79,940 shares0Common StockSEC:0001437749-22-019621:0
3,000 shares@ US$14.48893.7% of flowCommon StockSEC:0001437749-22-013310:0
Ideal exit: 14 Feb 2023 (T+270)
2,500 shares@ US$18.51723.7% of flowCommon StockSEC:0001437749-22-002873:0
Ideal exit: 4 Nov 2022 (T+270)
2,500 shares@ US$18.51727.6% of flowCommon StockSEC:0001437749-22-002873
Ideal exit: 4 Nov 2022 (T+270)
4,593 shares@ US$35.381.2% of flowCommon StockSEC:0000914190-21-000318
4,593 shares@ US$35.3812.5% of flowCommon StockSEC:0000914190-21-000318:0
27,842 shares0Common StockSEC:0000914190-21-000303:0
27,842 shares0Common StockSEC:0000914190-21-000303
10,570 shares@ US$36.072.7% of flowCommon StockSEC:0000914190-21-000265
10,570 shares@ US$36.0729.4% of flowCommon StockSEC:0000914190-21-000265:0
33,141 shares0Common StockSEC:0000914190-21-000235:0
33,141 shares0Common StockSEC:0000914190-21-000235
1,000 shares@ US$34.412.6% of flowCommon StockSEC:0000914190-21-000143
Ideal exit: 4 Feb 2022 (T+270)
1,000 shares@ US$34.412.6% of flowCommon StockSEC:0000914190-21-000143:0
Ideal exit: 4 Feb 2022 (T+270)
2,700 sharesCommon StockSEC:0000914190-16-000521:0
Ideal exit: 21 Oct 2016 (T+270)
20 of 20 declarations
About Ward Scott R.
Scott R. Ward is the Chairman and CEO of Cardiovascular Systems Inc. In this role, he is responsible for the strategic and operational leadership of the company. Ward plays a key role in business development and product innovation for Cardiovascular Systems, a company specializing in medical technologies. His expertise in management and strategy is essential for supporting the company's growth.
